Cite
HARVARD Citation
Ridolfi, L. et al. (n.d.). 48P Phase II trial on vaccination with autologous dendritic cells loaded with autologous tumour homogenate in resected glioblastoma (COMBI-GVAX): Clinical results of the first step. Immuno-oncology technology. p. . [Online].